188 related articles for article (PubMed ID: 29025593)
1. Prognostic significance of recurrent additional chromosomal abnormalities in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Seol CA; Cho YU; Jang S; Park CJ; Lee JH; Lee JH; Lee KH; Seo EJ
Cancer Genet; 2017 Oct; 216-217():29-36. PubMed ID: 29025593
[TBL] [Abstract][Full Text] [Related]
2. Poor outcomes associated with +der(22)t(9;22) and -9/9p in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving chemotherapy plus a tyrosine kinase inhibitor.
Short NJ; Kantarjian HM; Sasaki K; Ravandi F; Ko H; Cameron Yin C; Garcia-Manero G; Cortes JE; Garris R; O'Brien SM; Patel K; Khouri M; Thomas D; Jain N; Kadia TM; Daver NG; Benton CB; Issa GC; Konopleva M; Jabbour E
Am J Hematol; 2017 Mar; 92(3):238-243. PubMed ID: 28006851
[TBL] [Abstract][Full Text] [Related]
3. Additional Cytogenetic Abnormalities with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia on Allogeneic Stem Cell Transplantation in the Tyrosine Kinase Inhibitor Era.
Akahoshi Y; Mizuta S; Shimizu H; Uchida N; Fukuda T; Kanamori H; Onizuka M; Ozawa Y; Ohashi K; Ohta S; Eto T; Tanaka J; Atsuta Y; Kako S;
Biol Blood Marrow Transplant; 2018 Oct; 24(10):2009-2016. PubMed ID: 29908230
[TBL] [Abstract][Full Text] [Related]
4. Impact of Additional Cytogenetic Abnormalities in Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation.
Aldoss I; Stiller T; Cao TM; Palmer JM; Thomas SH; Forman SJ; Pullarkat V
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1326-9. PubMed ID: 25842050
[TBL] [Abstract][Full Text] [Related]
5. Frequency and prognostic significance of additional cytogenetic abnormalities to the Philadelphia chromosome in young and older adults with acute lymphoblastic leukemia.
Motlló C; Ribera JM; Morgades M; Granada I; Montesinos P; Mercadal S; González-Campos J; Moreno MJ; Barba P; Cervera M; Barrios M; Novo A; Bernal T; Hernández-Rivas JM; Abella E; Amigo ML; Tormo M; Martino R; Lavilla E; Bergua J; Serrano A; García-Belmonte D; Guàrdia R; Grau J; Feliu E;
Leuk Lymphoma; 2018 Jan; 59(1):146-154. PubMed ID: 28554259
[TBL] [Abstract][Full Text] [Related]
6. Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcome.
Heerema NA; Harbott J; Galimberti S; Camitta BM; Gaynon PS; Janka-Schaub G; Kamps W; Basso G; Pui CH; Schrappe M; Auclerc MF; Carroll AJ; Conter V; Harrison CJ; Pullen J; Raimondi SC; Richards S; Riehm H; Sather HN; Shuster JJ; Silverman LB; Valsecchi MG; Aricò M; ; ; ; ; ; ; ; ; ; ;
Leukemia; 2004 Apr; 18(4):693-702. PubMed ID: 15044926
[TBL] [Abstract][Full Text] [Related]
7. Clinical implications of cytogenetic heterogeneity in Philadelphia chromosome positive (Ph+) adult B cell acute lymphoblastic leukemia following tyrosine kinase inhibitors and chemotherapy regimens.
Jain P; Gu J; Kanagal-Shamanna R; Tang Z; Patel KP; Yao H; Fang L; Bao HY; Liu CH; Lin P; Medeiros LJ; Lu X
Leuk Res; 2019 Sep; 84():106176. PubMed ID: 31279181
[TBL] [Abstract][Full Text] [Related]
8. Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG).
Wrzesień-Kuś A; Robak T; Pluta A; Zwolińska M; Wawrzyniak E; Wierzbowska A; Skotnicki A; Jakubas B; Hołowiecki J; Nowak K; Kuliczkowski K; Mazur G; Haus O; Dmoszyńska A; Adamczyk-Cioch M; Jedrzejczak WW; Paluszewska M; Konopka L; Pałynyczko G
Ann Hematol; 2006 Jun; 85(6):366-73. PubMed ID: 16523310
[TBL] [Abstract][Full Text] [Related]
9. Clonal evolution detected with conventional cytogenetic analysis is a potent prognostic factor in adult patients with relapsed Philadelphia chromosome-negative acute lymphoblastic leukemia.
Shimizu H; Yokohama A; Ishizaki T; Hatsumi N; Takada S; Saitoh T; Sakura T; Handa H
Leuk Res; 2021 Apr; 103():106535. PubMed ID: 33611095
[TBL] [Abstract][Full Text] [Related]
10. Additional chromosomal abnormalities and their prognostic significance in adult Philadelphia-positive acute lymphoblastic leukemia: with or without imatinib in chemotherapy.
Li Y; Qiu L; Zou D; Zhao Y; Mi Y; Wang J
Ann Hematol; 2009 Nov; 88(11):1069-77. PubMed ID: 19277658
[TBL] [Abstract][Full Text] [Related]
11. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of philadelphia chromosome-positive acute lymphoblastic leukemia.
Chen H; Liu KY; Xu LP; Chen YH; Han W; Zhang XH; Wang Y; Qin YZ; Liu YR; Huang XJ
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1110-6. PubMed ID: 25698612
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors and outcomes of unrelated bone marrow transplantation for Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL) pre-treated with tyrosine kinase inhibitors.
Yoshimura T; Nakane T; Hirose A; Koh H; Nakamae M; Aimoto M; Nishimoto M; Hayashi Y; Terada Y; Nakamae H; Hino M
Osaka City Med J; 2013 Jun; 59(1):9-21. PubMed ID: 23909077
[TBL] [Abstract][Full Text] [Related]
13. Structure and significance of cytogenetic abnormalities in adult patients with Ph-negative acute lymphoblastic leukemia.
Piskunova IS; Obukhova TN; Parovichnikova EN; Kulikov SM; Troitskaya VV; Gavrilina OA; Savchenko VG
Ter Arkh; 2018 Aug; 90(7):30-37. PubMed ID: 30701920
[TBL] [Abstract][Full Text] [Related]
14. [Efficacies of hematopoietic stem cell transplantation plus imatinib in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia: a comparative study].
Chen J; Wu DP; Chen F; Zhao Y; Sun AN; Qiu HY
Zhonghua Yi Xue Za Zhi; 2013 Feb; 93(8):583-7. PubMed ID: 23663336
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
[TBL] [Abstract][Full Text] [Related]
16. Treatment of high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in adolescents and adults according to early cytologic response and minimal residual disease after consolidation assessed by flow cytometry: final results of the PETHEMA ALL-AR-03 trial.
Ribera JM; Oriol A; Morgades M; Montesinos P; Sarrà J; González-Campos J; Brunet S; Tormo M; Fernández-Abellán P; Guàrdia R; Bernal MT; Esteve J; Barba P; Moreno MJ; Bermúdez A; Cladera A; Escoda L; García-Boyero R; Del Potro E; Bergua J; Amigo ML; Grande C; Rabuñal MJ; Hernández-Rivas JM; Feliu E
J Clin Oncol; 2014 May; 32(15):1595-604. PubMed ID: 24752047
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic significance of Ph-positive acute lymphoblastic leukemia].
Zhou L; Hu J; Chen J; Du S; Wang A; You J; Wu W; Shen Z; Li J
Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):109-13. PubMed ID: 24606650
[TBL] [Abstract][Full Text] [Related]
18. Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial.
Moorman AV; Harrison CJ; Buck GA; Richards SM; Secker-Walker LM; Martineau M; Vance GH; Cherry AM; Higgins RR; Fielding AK; Foroni L; Paietta E; Tallman MS; Litzow MR; Wiernik PH; Rowe JM; Goldstone AH; Dewald GW;
Blood; 2007 Apr; 109(8):3189-97. PubMed ID: 17170120
[TBL] [Abstract][Full Text] [Related]
19. Philadelphia chromosome positive adult acute lymphoblastic leukemia: characteristics, prognostic factors and treatment outcome.
Thomas X; Thiebaut A; Olteanu N; Danaïla C; Charrin C; Archimbaud E; Fiere D
Hematol Cell Ther; 1998 Jun; 40(3):119-28. PubMed ID: 9698220
[TBL] [Abstract][Full Text] [Related]
20. [Clinical analysis of adult Philadelphia chromosome-positive acute lymphoblastic leukemia with p16 gene deletion].
He BL; Xu N; Li YL; Pan CY; Cao R; Liao LB; Yin CX; Lan YQ; Lu ZY; Huang JX; Zhou HS; Liu QF; Liu XL
Zhonghua Xue Ye Xue Za Zhi; 2017 Mar; 38(3):204-209. PubMed ID: 28395443
[No Abstract] [Full Text] [Related]
[Next] [New Search]
